Palantir Earnings and Outlook Fall Short of Estimates. The Stock Tumbles.

Palantir Earnings and Outlook Fall Short of Estimates. The Stock Tumbles.

Text size Palantir guided to a ‘base case’ of $470 million in revenue for the second quarter. Dreamstime Palantir Technologies posted soft first-quarter results, along with June quarter guidance that fell shy of previous Wall Street forecasts. Global economic and geopolitical forces appeared to be weighing on the company’s near-term outlook, although Palantir’s long-established ties … Read more

PLTR Stock Tumbles As Palantir Earnings, Revenue Guidance Miss

PLTR Stock Tumbles As Palantir Earnings, Revenue Guidance Miss

Palantir Technologies (PLTR) on Monday reported March-quarter earnings that missed views while revenue edged by Wall Street targets. PLTR stock plunged as revenue guidance came in below expectations amid slowing government growth. X Denver-based Palantir reported first-quarter earnings before the market open. Palantir stock plunged 15.6% to 8 in early trading on the stock market … Read more

Tyson Foods beats on profit and revenue

Tyson Foods beats on profit and revenue

Tyson Foods Inc. TSN, -0.09% shares rose 2.6% in Monday premarket trading after it reported fiscal second-quarter profit and revenue that beat Street expectations. The meat company posted net income of $829 million, or $2.28 per share, up from $476 million, or $1.30 per share, last year. Adjusted EPS of $2.29 blew past the FactSet … Read more

Bitcoin Is Proving It Isn’t Gold 2.0 as It’s Moving in Same Direction as Stocks

Bitcoin Is Proving It Isn’t Gold 2.0 as It’s Moving in Same Direction as Stocks

People buy bitcoins at a Coinstar ATM during an event in Miami last month. Getty Images Text size After a stormy week for markets, stock market futures are pointing down again Monday. Concerns that aggressive interest-rate increases, geopolitical tensions from Russia’s invasion of Ukraine, and another Covid-induced economic slump in China have already pulled the … Read more

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

Text size The BioNTech logo on the facade of its manufacturing site in Marburg, central Germany. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earnings and sales that topped Wall Street expectations. The company, which partnered with Pfizer to develop the first Covid-19 vaccine approved for use in the U.S., … Read more